PL394258A1 - Terapia skojarzona nowotworów gruczolu sutkowego - Google Patents

Terapia skojarzona nowotworów gruczolu sutkowego

Info

Publication number: PL394258A1
Authority: PL; Poland
Prior art keywords: breast cancer; combination therapy; analogues; vitamin; calcipotriol
Prior art date: 2011-03-18

Application number

PL394258A

Other languages

English (en)

Polish (pl)

Inventor

Joanna Wietrzyk

Beata Filip

Andrzej Kutner

Michał Chodyński

Original Assignee

Instytut Farmaceutyczny

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-18

Filing date

2011-03-18

Publication date

2012-09-24

2011-03-18 Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny

2011-03-18 Priority to PL394258A priority Critical patent/PL394258A1/pl

2012-03-16 Priority to PCT/PL2012/000012 priority patent/WO2012128653A1/fr

2012-09-24 Publication of PL394258A1 publication Critical patent/PL394258A1/pl

Links

206010006187 Breast cancer Diseases 0.000 title abstract 2
208000026310 Breast neoplasm Diseases 0.000 title abstract 2
238000002648 combination therapy Methods 0.000 title abstract 2
229930003316 Vitamin D Chemical class 0.000 abstract 2
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
229960002882 calcipotriol Drugs 0.000 abstract 2
LWQQLNNNIPYSNX-UROSTWAQSA-N calcipotriol Chemical compound C1([C@H](O)/C=C/[C@@H](C)[C@@H]2[C@]3(CCCC(/[C@@H]3CC2)=C\C=C\2C([C@@H](O)C[C@H](O)C/2)=C)C)CC1 LWQQLNNNIPYSNX-UROSTWAQSA-N 0.000 abstract 2
235000019166 vitamin D Nutrition 0.000 abstract 2
239000011710 vitamin D Chemical class 0.000 abstract 2
150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
229940046008 vitamin d Drugs 0.000 abstract 2
SSJXIUAHEKJCMH-WDSKDSINSA-N (1s,2s)-cyclohexane-1,2-diamine Chemical compound N[C@H]1CCCC[C@@H]1N SSJXIUAHEKJCMH-WDSKDSINSA-N 0.000 abstract 1
YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical class N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 abstract 1
229960002932 anastrozole Drugs 0.000 abstract 1
BJYLYJCXYAMOFT-RSFVBTMBSA-N tacalcitol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RSFVBTMBSA-N 0.000 abstract 1
229960004907 tacalcitol Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL394258A 2011-03-18 2011-03-18 Terapia skojarzona nowotworów gruczolu sutkowego PL394258A1 (pl)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
PL394258A PL394258A1 (pl)	2011-03-18	2011-03-18	Terapia skojarzona nowotworów gruczolu sutkowego
PCT/PL2012/000012 WO2012128653A1 (fr)	2011-03-18	2012-03-16	Utilisation d'anastrozole et d'analogue de vitamine d dans polythérapie contre le cancer du sein

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL394258A PL394258A1 (pl)	2011-03-18	2011-03-18	Terapia skojarzona nowotworów gruczolu sutkowego

Publications (1)

Publication Number	Publication Date
PL394258A1 true PL394258A1 (pl)	2012-09-24

Family

ID=46045055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL394258A PL394258A1 (pl)	2011-03-18	2011-03-18	Terapia skojarzona nowotworów gruczolu sutkowego

Country Status (2)

Country	Link
PL (1)	PL394258A1 (fr)
WO (1)	WO2012128653A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL339112A1 (en)	2000-03-21	2001-09-24	Inst Farmaceutyczny	Pharmacological agent exhibiting aniticarcinogenic effect, application of 1,25-diydoxycholecalcipherol analoques and method of treating neoplasms
PL378586A1 (pl)	2005-12-29	2007-07-09	Instytut Farmaceutyczny	Zastosowanie analogów kalcypotriolu w leczeniu chorób nowotworowych
US20110124617A1 (en) *	2008-05-09	2011-05-26	Lyttle C Richard	Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent
PL388252A1 (pl) *	2009-06-10	2010-12-20	Instytut Farmaceutyczny	Terapia skojarzona raka jelita grubego

2011
- 2011-03-18 PL PL394258A patent/PL394258A1/pl not_active Application Discontinuation
2012
- 2012-03-16 WO PCT/PL2012/000012 patent/WO2012128653A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2012128653A1 (fr)	2012-09-27

Similar Documents

Publication	Publication Date	Title
PH12014502452A1 (en)	2015-02-02	Gip-glp-1 dual agonist compounds and methods
PH12014502010A1 (en)	2014-11-24	Bispecific antibodies against human tweak and human il17 and uses thereof
UY33735A (es)	2012-06-29	Compuestos antivirales
MD20150091A2 (ro)	2016-02-29	Compuşi antivirali
PH12013501871A1 (en)	2019-06-03	Cyclopropylamines as lsd1 inhibitors
CR20140190A (es)	2014-05-26	Piridopirazinas anticancerigenas via la inhibición de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr)
MX2013008737A (es)	2013-08-14	Formas de dosificacion oral para tasocitinib que comprende liberacion modificada.
PH12014501273A1 (en)	2014-09-08	Intranasal dexmedetomidine compositions and methods of use thereof
PH12013500529A1 (en)	2017-08-09	Methods and compositions for treating lung cancer
WO2009047644A3 (fr)	2009-05-28	Procédé de traitement d'une insuffisance et d'une carence en vitamine d
MY173521A (en)	2020-01-30	Trpv4 antagonists
PH12013501481A1 (en)	2013-08-28	Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
MX344473B (es)	2016-12-16	Composicion farmaceutica acuosa semisolida que contiene tapentadol.
MY168300A (en)	2018-10-25	Pharmaceutical Composition for Inhalation
MX2014004196A (es)	2014-05-28	Citramida de rasagilina.
EA201490760A1 (ru)	2014-09-30	R(+)-n-метилпропаргиламиноиндан
MX356025B (es)	2018-05-09	Uso de glicopirrolato para tratar taquicardia.
WO2014039533A3 (fr)	2015-07-16	Prévention de la rechute du cancer pulmonaire avec un complexe lipide/cisplatine
CL2013003324A1 (es)	2014-08-01	Composicion que comprende quimioterapia con paclitaxel y carboplatino y un oligonucleotido anti-clusterina; uso de la composición para el tratamiento de un paciente humano que padece cancer de pulmón.
MY166314A (en)	2018-06-25	Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
PH12013500275A1 (en)	2017-08-23	Novel trpv3 modulators
MX347541B (es)	2017-04-28	Analogos de acido sialico.
PH12014501327A1 (en)	2014-09-15	Processes for making magnolol analogs
MX2013000539A (es)	2013-04-11	Nuevas formulaciones de analogos 14-epi de la vitamina d.
MX2015011588A (es)	2015-12-09	Tratamiento de combinacion.

Legal Events

Date	Code	Title	Description
2015-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)